US$ 23.34
amylin glp 1 dual agonist receptor agonism enhances the effects of liraglutide in protecting against the acute metabolic side effects of olanzapine Novo's GLP-1/Amylin Dual Agonist Amycretin
Description
BMJ Open 8 , e022599 (2018)

Marso et al., 2016

Data Analysis: Matching with Cox proportional hazards models to estimate hazard ratios (HRs) with 95% CIs

Symptoms include severe abdominal pain, nausea, and vomiting

Starting at the lowest dose and increasing the dose gradually over time may help to minimize side effects

In clinical trials with participants with obesity, 5 mg, 10 mg, or 15 mg of tirzepatide once weekly provided substantial and sustained reductions in body weight over 72 weeks [22]
